You must have typed the wrong URL address or you must have used an outdated link to reach this page.
THE LIBRARY: WEBINAR
Achieving Proof-of-Concept Data for Inflammation Drug Studies
On May 2 at 11 a.m. EST FierceBiotech will host a one-hour webinar with top clinical investigators sharing their insights on the new technologies and strategies now in play to help improve studies for drugs in the inflammation field. Their ideas are relevant for everyone in the R&D world. Register Today!
Press Releases
- Oracle Buys ClearTrial
- Sunesis and Royalty Pharma Announce $25 Million Vosaroxin Royalty Agreement
- Genalyte, Inc. Completes $12 Million Series B Financing to Commercialize Its Maverick™ Next-Generation Multiplexing Platform
- HeartWare International Expands Intellectual Property and Technology Portfolio Through Definitive Agreement to Acquire World Heart Corporation for US$8 Million
- Shire announces top-line results of the PREVENT2 trial
Latest Commentary